|

Histrelin Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • NRG Oncology1
  • Mayo Clinic1

Indications

  • Cancer2
  • Biochemically Recurrent Prostate Carcinoma1
  • Recurrent Castration-Sensitive Prostate Carcinoma1
  • Castration-resistant Prostate Cancer1
  • Recurrent Prostate Cancer1

Birmingham, Alabama1 trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

University of Alabama at Birmingham Cancer Center

Phase 3

Phoenix, Arizona1 trial

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Mayo Clinic in Arizona

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.